ArticleRevista medica del Instituto Mexicano del Seguro Social2024
[Use of ultrasound in vein of Galen malformation].
Article in Revista medica del Instituto Mexicano del Seguro Social, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Aneurysmal malformation of the vein of Galen (AVMG) is a rare malformation of the intracranial venous system. The incidence is estimated at 1:10,000-25,0000 births. The clinical picture is very variable, in the neonatal period it includes seizures and heart failure. It is very difficult to diagnose, but by doing it in a timely manner, mortality is greatly reduced. It can be detected by prenatal ultrasounds and, at birth, the gold standard imaging study for its diagnosis is cerebral resonance and angioresonance. However, 50% of AVMG cannot be corrected and there is evidence that 77% of untreated cases result in death. Clinical case: The case of a newborn with a prenatal diagnosis is presented and at birth the diagnosis of MAVG was corroborated by neurosonography, and subsequently confirmed by venoresonance. His clinical evolution was documented, which included placement of a ventriculoperitoneal shunt and vascular embolization; however, there was a fatal outcome. Conclusions: In MAVG it is important to define the anatomy of the lesion, due to the clinical, therapeutic and prognostic implications that this represents. B-mode ultrasound, together with Doppler mode, are essential complementary tools for the diagnosis of AVMG, as well as for prognostic evaluation and to provide information for counseling parents and for optimal management. Successful treatment remains a complex therapeutic challenge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.